So Far, PCSK9 Inhibitors Work for All Heterozygous FH Patients

Research output: Contribution to journalEditorialpeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)749-751
Number of pages3
JournalCirculation: Cardiovascular Genetics
Volume8
Issue number6
DOIs
StatePublished - Dec 1 2015

Keywords

  • Editorials
  • LDLR
  • PCSK9
  • cardiovascular disease
  • hypercholesterolemia
  • lipoprotein
  • pharmacology
  • treatment

ASJC Scopus subject areas

  • Genetics
  • Cardiology and Cardiovascular Medicine
  • Genetics(clinical)

Cite this